Clinical Trials Toxicology

Course aim

For students to describe the steps required to develop safe and effective medicines dosage design for clinical trials research.

Course content

Pharmacokinetic drug interactions; Bioavailability and bioequivalence; evaluation of the biopharmaceutical performance of dosage forms; preclinical pharmacology and toxicology; drug discovery and development; optimisation of candidate molecules; New Chemical Entities (NCE); side effects; toxicities; compound identification; lead optimisation; pharmaceutical profiling; the use of animal models to predict efficacy and safety; study validation; toxicological assessment; reproductive and developmental toxicology.

Textbook(s)

Nil

Prerequisite(s)

Corequisite(s)

Nil

Teaching method

Note: These components may or may not be scheduled in every study period. Please refer to the timetable for further details.

Assessment

Report, Test/Quiz

Fees

EFTSL*: 0.125
Commonwealth Supported program (Band 2)
To determine the fee for this course as part of a Commonwealth Supported program, go to:
How to determine your Commonwealth Supported course fee. (Opens new window)

Fee-paying program for domestic and international students
International students and students undertaking this course as part of a postgraduate fee paying program must refer to the relevant program home page to determine the cost for undertaking this course.

Non-award enrolment
Non-award tuition fees are set by the university. To determine the cost of this course, go to:
How to determine the relevant non award tuition fee. (Opens new window)

Not all courses are available on all of the above bases, and students must check to ensure that they are permitted to enrol in a particular course.

* Equivalent Full Time Study Load. Please note: all EFTSL values are published and calculated at ten decimal places. Values are displayed to three decimal places for ease of interpretation.